These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9696398)

  • 61. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The clinical utility of Ki-67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids.
    Liu E; Telem DA; Hwang J; Warner RR; Dikman A; Divino CM
    J Surg Oncol; 2010 Sep; 102(4):338-41. PubMed ID: 20607756
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics.
    Steck K; Hunt K; Tucker S; Singletary S; El-Naggar AK
    Oncol Rep; 1999; 6(4):835-8. PubMed ID: 10373666
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models.
    van Weerden WM; Moerings EP; van Kreuningen A; de Jong FH; van Steenbrugge GJ; Schröder FH
    Cell Prolif; 1993 Jan; 26(1):67-75. PubMed ID: 8439590
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Magnetic field exposure increases cell proliferation but does not affect melatonin levels in the mammary gland of female Sprague Dawley rats.
    Fedrowitz M; Westermann J; Löscher W
    Cancer Res; 2002 Mar; 62(5):1356-63. PubMed ID: 11888905
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer.
    Vera-Badillo FE; Chang MC; Kuruzar G; Ocana A; Templeton AJ; Seruga B; Goldstein R; Bedard PL; Tannock IF; Amir E
    J Clin Pathol; 2015 Oct; 68(10):839-43. PubMed ID: 26076967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Long-term Prognostic Performance of Ki-67 in Primary Operable Breast Cancer and Evaluation of Its Optimal Cutoff Value.
    Cho U; Kim HE; Oh WJ; Yeo MK; Song BJ; Lee A
    Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):159-66. PubMed ID: 25789536
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index.
    Jalava P; Kuopio T; Juntti-Patinen L; Kotkansalo T; Kronqvist P; Collan Y
    Histopathology; 2006 May; 48(6):674-82. PubMed ID: 16681683
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus.
    Sarbia M; Bittinger F; Porschen R; Dutkowski P; Torzewski M; Willers R; Gabbert HE
    Br J Cancer; 1996 Oct; 74(7):1012-6. PubMed ID: 8855967
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
    Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
    Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine.
    Christov K; Chew KL; Ljung BM; Waldman FM; Duarte LA; Goodson WH; Smith HS; Mayall BH
    Am J Pathol; 1991 Jun; 138(6):1371-7. PubMed ID: 2053594
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferation indices.
    Maier H; Morimura T; Ofner D; Hallbrucker C; Kitz K; Budka H
    Acta Neuropathol; 1990; 80(2):156-62. PubMed ID: 2389680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bromodeoxyuridine labelling of transitional cell carcinoma of the bladder--an index of recurrence?
    Popert RJ; Joyce AD; Thomas DJ; Walmsley BH; Coptcoat MJ
    Br J Urol; 1993 Mar; 71(3):279-83. PubMed ID: 8477314
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
    Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
    Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears.
    Dalquen P; Baschiera B; Chaffard R; Dieterich H; Feichter GE; Krmer K; Torhorst J
    Acta Cytol; 1997; 41(2):229-37. PubMed ID: 9100748
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.
    Kim HS; Park S; Koo JS; Kim S; Kim JY; Nam S; Park HS; Kim SI; Park BW
    PLoS One; 2016; 11(3):e0151054. PubMed ID: 26954364
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.
    Şahin S; Işık Gönül İ; Çakır A; Seçkin S; Uluoğlu Ö
    Int J Surg Pathol; 2016 Oct; 24(7):607-13. PubMed ID: 27284123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.